For instance, trastuzumab (a monoclonal antibody) is designed to target the HER2 receptor in the case of HER2-positive tumors, where it has demonstrated a significant improvement in survival rates (disease-free as well as overall survival) in early stage and metastatic disease settings (217)
[10] Swerdlow AJ, Cooke R, Beckers D, Borgstrm B, Butler G, Carel JC, Cianfarani S, Clayton P, Coste J, Deodati A, Ecosse E, Gausche R, Giacomozzi C, Hokken-Koelega ACS, Khan AJ, Kiess W, Kuehni CE, Mullis PE, Pfaffle R, Svendahl L, Sommer G, Thomas M, Tidblad A, Tollerfield S, Van Eycken L, Zandwijken GRJ
Q: When will I see results
Some information within reports including certain batch identifiers may be redacted
Unfortunately, patients and providers will often chalk these symptoms up to stress, general aging, and burnout, instead of addressing the underlying cause: hormonal imbalance